- STIRIPENTOL
-
- $714.30 / 1Kg/Bag
-
2021-11-02
- CAS:49763-96-4
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 500kg
- STIRIPENTOL USP/EP/BP
-
- $1.10 / 1g
-
2021-08-18
- CAS:49763-96-4
- Min. Order: 1g
- Purity: 99.9%
- Supply Ability: 100 Tons min
- Stiripentol
-
- $15.00 / 1KG
-
2021-07-02
- CAS:49763-96-4
- Min. Order: 1KG
- Purity: 99%+ HPLC
- Supply Ability: Monthly supply of 1 ton
|
| STIRIPENTOL Basic information |
Product Name: | STIRIPENTOL | Synonyms: | (RS)-(E)-4,4-dimethyl-1-[3,4(methylenedioxy)-phenyl]-1-penten-3-ol;1-(1,3-BENZODIOXOL-5YL)-4,4-DIMETHYL-1-PENTEN-3-OL;STIRIPENTOL;1-(1,3-benzodioxol-5-yl)-4,4-dimethyl-1-penten-3-o;4,4-dimethyl-1-(3,4-methylenedioxyphenyl)-1-penten-3-o;4,4-dimethyl-1-(3,4-methylenedioxyphenyl)-1-penten-3-ol;bcx2600;1-(Benzo[d][1,3]dioxol-5-yl)-4,4-dimethylpent-1-en-3-ol | CAS: | 49763-96-4 | MF: | C14H18O3 | MW: | 234.29 | EINECS: | 256-480-9 | Product Categories: | Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals | Mol File: | 49763-96-4.mol | |
| STIRIPENTOL Chemical Properties |
Melting point | 73-74°C | Boiling point | 365.4±11.0 °C(Predicted) | density | 1.139±0.06 g/cm3(Predicted) | storage temp. | -20°C | solubility | DMSO: ≥20mg/mL | pka | 14.45±0.20(Predicted) | form | powder | color | white to beige | InChIKey | IBLNKMRFIPWSOY-FNORWQNLSA-N | CAS DataBase Reference | 49763-96-4 |
Hazard Codes | Xn | Risk Statements | 22 | WGK Germany | 3 | RTECS | SB3393000 | HS Code | 2932.99.7000 |
| STIRIPENTOL Usage And Synthesis |
Description | Stiripentol is a third-generation antiepileptic compound. It is a positive allosteric modulator of GABAA receptors, potentiating GABA-mediated activation to a greater extent in receptors expressing α3 subunits and to a lower extent in those containing β1 or ε subunits. It also inhibits GABA reuptake in vitro and increases the release of GABA in neonatal rat hippocampal slices. Stiripentol (500 μM) inhibits lactate dehydrogenase (LDH), blocking both lactate-to-pyruvate and pyruvate-to-lactate conversions by human LDH1 and LDH5. Formulations containing stiripentol have been used in the adjunctive treatment of seizures associated with Dravet syndrome. | Chemical Properties | White Solid | Uses | Stiripentol has been used in pharmacokinetic analysis and as a reference standard in fluorescence spectra analysis. | Uses | An antiepileptic drug | Uses | Stiripentol is an epilepsy drug, it has been used as co-therapy for treatment of epilepsy. | Definition | ChEBI: 1-(1,3-benzodioxol-5-yl)-4,4-dimethyl-1-penten-3-ol is a phenylpropanoid. | Biochem/physiol Actions | Anti-convulsant drug |
| STIRIPENTOL Preparation Products And Raw materials |
|